Clinical Trials of Hepatitis B Immune Globulin
Authors:
- D. Mac N. SurgenorDSD. Mac N. Surgenor
- Thomas C. ChalmersTCThomas C. Chalmers
- Marcel E. ConradMCMarcel E. Conrad
- William T. FriedewaldWFWilliam T. Friedewald
- George F. GradyGGGeorge F. Grady
- Michael HamiltonMHMichael Hamilton
- James W. MosleyJMJames W. Mosley
- Alfred M. PrinceAPAlfred M. Prince
- James M. StengleJSJames M. Stengle
- 20 November 1975
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 293 (21) , 1060-1062
Abstract
Plasma from persons with high titers of hepatitis B antibody (anti-HBs) was used to manufacture one lot of hepatitis B "immune" globulin sufficient for four interlocking clinical trials of prevention or modification of hepatitis B infections. The trials were carried out in renal dialysis units, in medical personnel with accidental exposures to hepatitis B, in transfused patients, and in patients with fulminant hepatitis. A single policy board developed protocols that allowed comparisons among the four studies while respecting the unique requirements of each. (N Engl J Med 293: 1060–1062,1975)Keywords
This publication has 7 references indexed in Scilit:
- Hepatitis B Immune Globulin — Prevention of Hepatitis from Accidental Exposure among Medical PersonnelNew England Journal of Medicine, 1975
- Hepatitis B “Immune” Globulin: Effectiveness in Prevention of Dialysis-Associated HepatitisNew England Journal of Medicine, 1975
- Human Hepatitis B Antibody: Evaluation of Assays and Development of a Reference PanelTransfusion, 1974
- Risk of posttransfusion hepatitis in the United States. A prospective cooperative study1972
- GAMMA-GLOBULIN FOR HEPATITIS-VIRUS B PREVENTION OR EXTENSION ?The Lancet, 1972
- Viral hepatitis, type B (MS-2 strain) prevention with specific hepatitis B immune serum globulin1971
- Antibody against Serum-Hepatitis AntigenNew England Journal of Medicine, 1971